Terms: = Kidney tumors AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Treatment
302 results:
1. Pazopanib stimulates senescence of renal carcinoma cells through targeting nuclear factor E2-related factor 2 (Nrf2).
Wang X; Yang J; Li D; Teng L; Chen Y; Meng J; Yang C; Yin Z; Li C
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23689. PubMed ID: 38613465
[TBL] [Abstract] [Full Text] [Related]
2. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast Cancer: A Randomized Clinical Study.
Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
[TBL] [Abstract] [Full Text] [Related]
3. Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.
Yang Z; Jiang Y; Wang L; Yu B; Cai H; Fan J; Zhang M
BMC Med Genomics; 2024 Feb; 17(1):60. PubMed ID: 38383432
[TBL] [Abstract] [Full Text] [Related]
4. Identification of Erzhu Jiedu Recipe and its molecular mechanism underlying inhibited human hepatoma cells by UHPLC-Q-Exactive Orbitrap HRMS and network pharmacology.
Wang F; Mai J; Wang H; Xu Y; Zhou X; Xie Z; Yu B; Liu P; Liu W; Cheng Y
J Ethnopharmacol; 2024 May; 325():117893. PubMed ID: 38336184
[TBL] [Abstract] [Full Text] [Related]
5. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
6. Tissue Organoid Cultures Metabolize Dietary Carcinogens Proficiently and Are Effective Models for DNA Adduct Formation.
Caipa Garcia AL; Kucab JE; Al-Serori H; Beck RSS; Bellamri M; Turesky RJ; Groopman JD; Francies HE; Garnett MJ; Huch M; Drost J; Zilbauer M; Arlt VM; Phillips DH
Chem Res Toxicol; 2024 Feb; 37(2):234-247. PubMed ID: 38232180
[TBL] [Abstract] [Full Text] [Related]
7. The role of single-cell RNA sequencing in cardiac tumour - a case report.
Qi XJ; Wei T; Abba IA; Zhang SQ; Meng JJ; Shi C; Jiang Y
J Pak Med Assoc; 2023 Dec; 73(12):2462-2464. PubMed ID: 38083933
[TBL] [Abstract] [Full Text] [Related]
8. Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors.
Su X; Lu X; Bazai SK; Dainese L; Verschuur A; Dumont B; Mouawad R; Xu L; Cheng W; Yan F; Irtan S; Lindner V; Paillard C; Le Bouc Y; Coulomb A; Malouf GG
Nat Commun; 2023 Nov; 14(1):7884. PubMed ID: 38036539
[TBL] [Abstract] [Full Text] [Related]
9. A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage.
Uno K; Rastegar B; Jansson C; Durand G; Valind A; Chattopadhyay S; Bertolotti A; Ciceri S; Spreafico F; Collini P; Perotti D; Mengelbier LH; Gisselsson D
Mod Pathol; 2024 Jan; 37(1):100382. PubMed ID: 37951357
[TBL] [Abstract] [Full Text] [Related]
10. Exploring the material basis and mechanism of action of clinacanthus nutans in treating renal cell carcinoma based on metabolomics and network pharmacology.
Ye Z; Fang Z; Li D; Lin X; Huang S
Medicine (Baltimore); 2023 Oct; 102(42):e35675. PubMed ID: 37861516
[TBL] [Abstract] [Full Text] [Related]
11. Modulation of mammary tumour progression using murine model by ethanol root extract of Saussurea costus (falc.) lipsch.
Kumar R; Bhardwaj P; Soni M; Singh R; Choudhary S; Virmani N; Asrani RK; Patial V; Sharma D; Gupta VK; Tripathi BN
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117302. PubMed ID: 37858751
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus.
Nakayama Y; Enomoto D; Yamamoto K; Takara K
Anticancer Res; 2023 Oct; 43(10):4349-4357. PubMed ID: 37772579
[TBL] [Abstract] [Full Text] [Related]
13. Immunohistochemical expression of p53 protein in nephroblastoma: a predictor of unfavorable prognosis.
Morgan ED; Yahaya JJ; Ngaiza AI; Othieno E; Livex OA
J Egypt Natl Canc Inst; 2023 Jul; 35(1):23. PubMed ID: 37518096
[TBL] [Abstract] [Full Text] [Related]
14. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
[TBL] [Abstract] [Full Text] [Related]
15. Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma.
Yuan H; Qin X; Yang Q; Liu L; Fang Z; Fan Y; Xu D
Biol Sex Differ; 2023 Jul; 14(1):46. PubMed ID: 37434223
[TBL] [Abstract] [Full Text] [Related]
16. Silence of linc00023 inhibits pyroptosis and promotes cell proliferation via regulating p53.
Zhu A; Cheng C; Lin S; Hong Z; Shi Z; Deng H; Zhang G
Gene; 2023 Oct; 882():147628. PubMed ID: 37429368
[TBL] [Abstract] [Full Text] [Related]
17. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract] [Full Text] [Related]
18. Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway.
Li L; Li M; Zheng J; Li Z; Chen X
Aging (Albany NY); 2023 Jun; 15(11):4757-4773. PubMed ID: 37263638
[TBL] [Abstract] [Full Text] [Related]
19. Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy.
Shapiro DD; Zacharias NM; Tripathi DN; Karki M; Bertocchio JP; Soeung M; He R; Westerman ME; Gao J; Rao P; Lam TNA; Jonasch E; Perelli L; Cheng EH; Carugo A; Heffernan TP; Walker CL; Genovese G; Tannir NM; Karam JA; Msaouel P
Clin Transl Med; 2023 May; 13(5):e1267. PubMed ID: 37226898
[TBL] [Abstract] [Full Text] [Related]
20. Identification of circulating tumour DNA (ctDNA) from the liquid biopsy results: Findings from an observational cohort study.
Myint KZY; Shimabuku M; Horio R; Kaneda M; Shimizu Y; Taguchi J
Cancer Treat Res Commun; 2023; 35():100701. PubMed ID: 37094468
[TBL] [Abstract] [Full Text] [Related]
[Next]
